Literature DB >> 22249838

Multiple sclerosis: 'Outside-in' demyelination in MS.

Katy Malpass.   

Abstract

Entities:  

Year:  2012        PMID: 22249838     DOI: 10.1038/nrneurol.2011.217

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Inflammatory cortical demyelination in early multiple sclerosis.

Authors:  Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

  1 in total
  5 in total

1.  Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice.

Authors:  Jun Zhang; Andrew Lapato; Sheetal Bodhankar; Arthur A Vandenbark; Halina Offner
Journal:  Metab Brain Dis       Date:  2015-03-18       Impact factor: 3.584

2.  The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation.

Authors:  Cinzia Volonté; Savina Apolloni; Susanna Amadio
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Atmospheric particulate matter aggravates cns demyelination through involvement of TLR-4/NF-kB signaling and microglial activation.

Authors:  Bing Han; Xing Li; Ruo-Song Ai; Si-Ying Deng; Ze-Qing Ye; Xin Deng; Wen Ma; Shun Xiao; Jing-Zhi Wang; Li-Mei Wang; Chong Xie; Yan Zhang; Yan Xu; Yuan Zhang
Journal:  Elife       Date:  2022-02-24       Impact factor: 8.140

Review 4.  Role of lipoic acid in multiple sclerosis.

Authors:  Hongsheng Xie; Xiufang Yang; Yuan Cao; Xipeng Long; Huifang Shang; Zhiyun Jia
Journal:  CNS Neurosci Ther       Date:  2021-12-28       Impact factor: 5.243

Review 5.  Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes.

Authors:  Pekka Poutiainen; Merja Jaronen; Francisco J Quintana; Anna-Liisa Brownell
Journal:  Front Mol Neurosci       Date:  2016-09-15       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.